Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,540 | 62,476 | 52,891 | 136,252 | 196,808 |
| Marketable Securities | 3,204 | 46,236 | 139,212 | 142,779 | 38,156 |
| Receivables | 26,178 | 30,766 | 26,962 | 47,086 | 22,497 |
| Inventories | 4,038 | 4,739 | 3,043 | 4,224 | 4,106 |
| TOTAL | $103,146 | $156,462 | $233,921 | $350,162 | $275,606 |
| Non-Current Assets | |||||
| PPE Net | 104 | 400 | 606 | 1,139 | 1,642 |
| Other Non-Current Assets | 5,166 | 7,556 | 5,911 | 6,871 | 28,057 |
| TOTAL | $5,270 | $7,956 | $6,517 | $8,010 | $29,699 |
| Total Assets | $108,416 | $164,418 | $240,438 | $358,172 | $305,305 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,010 | 24,426 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,003 | 5,107 | 3,123 | 2,773 | 1,603 |
| Accrued Expenses | 64,498 | 60,652 | 61,394 | 58,415 | 69,121 |
| Other current liabilities | 1,580 | 1,641 | 1,654 | 1,848 | 678 |
| TOTAL | $92,060 | $92,264 | $69,479 | $65,908 | $73,718 |
| Non-Current Liabilities | |||||
| Long Term Debt | 94,795 | 94,603 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 214,487 | 163,568 | 307,165 | 308,920 | 311,260 |
| TOTAL | $309,282 | $258,171 | $307,165 | $308,920 | $311,260 |
| Total Liabilities | $401,342 | $350,435 | $376,644 | $374,828 | $384,978 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,344 | 8,420 | 7,675 | 7,560 | 5,280 |
| Common Shares | 14 | 13 | 12 | 12 | 8 |
| Retained earnings | -1,759,499 | -1,563,460 | -1,487,038 | -1,343,939 | -1,178,648 |
| Other shareholders' equity | 71 | -356 | -161 | -638 | 191 |
| TOTAL | $-292,926 | $-186,017 | $-136,206 | $-16,656 | $-79,673 |
| Total Liabilities And Equity | $108,416 | $164,418 | $240,438 | $358,172 | $305,305 |